Celsius Therapeutics Names Jeanne Magram Chief Scientific Officer

Celsisus Therapeutics has appointed Jeanne Magram to serve as the Cambridge, MA-based drug developer’s chief scientific officer. She was most recently the CSO of Quentis Therapeutics. Magram’s experience also includes positions at Northern Biologics, Pfizer (NYSE: [[ticker:PFE]]), Boehringer Ingelheim, OSI Pharmaceuticals, and Roche. Celsius is using single-cell genomics to develop new treatments for cancer and autoimmune diseases, launched in 2018 backed by $65 million in Series A financing.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.